Literature DB >> 7362559

Permeability changes in cerebral, iridic, and retinal vessels during experimental decompression sickness in the rat.

T Tervo, J Lehtosalo, V P Lehto, M Heino, I Kantola, L A Laitinen.   

Abstract

An investigation has been made of the effect of acute decompression sickness upon the permeability of the cerebral, iridic, and retinal vessels of the rat, with sodium-fluorescein as intravenous tracer. No permeability changes were observable during the first 15 min subsequent to decompression, following exposure to 5.1 bar for 50 min. Focal leaky areas were found in the brain parenchyma after exposures to 5.1 bar for 120 min. Although sodium-fluorescein partially permeated the pial vessels in controls, the treatment in a hyperbaric chamber seems to increase the diffusion of the tracer from the pia into the cerebral cortex. Nevertheless, both the iridic and retinal vessels remained "tight." The factors which increase the permeability of microvasculature in brain and possible reasons for the negative results obtained with the iris and retina in decompression sickness are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7362559

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  3 in total

1.  Bubbles and hematologic alterations in intracranial veins during experimental decompression sickness.

Authors:  J Lehtosalo; T Tervo; L A Laitinen
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

2.  The permeability alteration of brain and spinal cord vasculature to horseradish peroxidase during experimental decompression sickness as compared to the alteration in permeability induced by hyperosmolar solution.

Authors:  J Lehtosalo; P Panula; L A Laitinen
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

3.  Ethanol and acetaldehyde do not increase the blood-brain and blood-retinal barrier permeability to sodium fluorescein.

Authors:  M E Hillbom; T M Tervo
Journal:  Experientia       Date:  1981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.